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We examined the effects of graded muscle glycogen on the subcellular location and
protein content ofAMP-activatedprotein kinase (AMPK) andperoxisomeproliferator-
activated receptor γ coactivator 1α (PGC-1α) and mRNA expression of genes
associated with the regulation of mitochondrial biogenesis and substrate utilisation
in human skeletal muscle. In a repeated measures design, eight trained male cyclists
completed acute high-intensity interval (HIT) cycling (8 × 5 min at 80% peak power
output) with graded concentrations of pre-exercise muscle glycogen. Following initial
glycogen-depleting exercise, subjects ingested 2 g kg−1 (L-CHO), 6 g kg−1 (M-CHO)
or 14 g kg−1 (H-CHO) of carbohydrate during a 36 h period, such that exercise was
commenced with graded (P < 0.05) muscle glycogen concentrations (mmol (kg dw)−1:
H-CHO, 531 ± 83; M-CHO, 332 ± 88; L-CHO, 208 ± 79). Exercise depleted muscle
glycogen to <300 mmol (kg dw)−1 in all trials (mmol (kg dw)−1: H-CHO, 270 ± 88;
M-CHO, 173 ± 74; L-CHO, 100 ± 42) and induced comparable increases in nuclear
AMPK protein content (∼2-fold) and PGC-1α (∼5-fold), p53 (∼1.5-fold) and carnitine
palmitoyltransferase 1 (∼2-fold) mRNA between trials (all P< 0.05). The magnitude of
increase in PGC-1αmRNA was also positively correlated with post-exercise glycogen
concentration (P < 0.05). In contrast, neither exercise nor carbohydrate availability
affected the subcellular location of PGC-1α protein or PPAR, SCO2, SIRT1, DRP1,
MFN2 or CD36 mRNA. Using a sleep-low, train-low model with a high-intensity end-
urance exercise stimulus, we conclude that pre-exercise muscle glycogen does not
modulate skeletal muscle cell signalling.
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1 INTRODUCTION
The concept of deliberately commencing endurance exercise with
reduced muscle glycogen (i.e. the train-low paradigm, Burke et al.,
2018) is now recognised as a potent nutritional strategy that is
able to modulate acute skeletal muscle cell signalling (Bartlett et al.,
2013; Wojtaszewski et al., 2003; Yeo et al., 2010) and transcriptional
responses (Bartlett et al., 2013; Pilegaard et al., 2002; Psilander, Frank,
Flockhart, & Sahlin, 2013). Furthermore, repeated bouts of train-low
exercise can subsequently augmentmany hallmarkmuscle adaptations
inherent to the endurance phenotype. Indeed, the strategic peri-
odisation of dietary carbohydrate (CHO) in order to commence
exercise with low muscle glycogen (during 3–10 weeks of training)
enhances mitochondrial enzyme activity and protein content (Hansen
et al., 2005; Morton et al., 2009; Yeo et al., 2008) and whole body
and intra-muscular lipid metabolism (Hulston et al., 2010), and, in
some instances, improves exercise capacity (Hansen et al., 2005) and
performance (Marquet et al., 2016a, 2016b). As such, the train-low
paradigm and wider CHO periodisation strategies have subsequently
gained increased recognition amongst athletic populations (Burke
et al., 2018; Impey et al., 2018; Stellingwerff, 2012).
Skeletal muscle glycogen appears to exert its regulatory effects
primarily through the AMP-activated protein kinase (AMPK)–
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-
1α) signalling axis, whereby exercise-induced AMPKα2 activity
(Wojtaszewski et al., 2003), phosphorylation (Yeo et al., 2010) and
nuclear abundance (Steinberg et al., 2006) are all augmented under
conditions of reduced pre-exercisemuscle glycogen. These effectsmay
be partly mediated through the glycogen binding domain present on
the β subunit of AMPK (McBride &Hardie, 2009;McBride, Ghilagaber,
Nikolaev, & Hardie, 2009). This allows for the physical tethering of
AMPK to the glycogen granule and may subsequently inhibit its trans-
location to the nucleus and its activation of transcriptional regulatory
proteins. In this way, the subcellular localisation of AMPK may play an
important role in the signal transduction pathway regulating train-low
responses, whereby its translocation to the nucleus could allow for
interaction with transcriptional regulatory proteins, such as PGC-1α,
to control gene expression (McGee et al., 2003). Indeed, endurance
exercise also appears to increase the nuclear abundance of PGC-1α
(Little, Safdar, Cermak, Tarnopolsky, & Gibala, 2010; Little, Safdar,
Bishop, Tarnopolsky, & Gibala, 2011), and may constitute the initial
phase of exercise-induced adaptive responses.
Despite the potential regulatory role ofmuscle glycogen availability
in exercise-induced cell signalling, the absolute concentrations of
muscle glycogen required to facilitate such responses are currently
unknown (Impey et al., 2018). Recent suggestions propose the
potential existence of a muscle glycogen threshold, a metabolic
window of absolute muscle glycogen concentration whereby the
augmented signalling and transcriptional responses associated with
train-lowmodels are particularly evident (Impey et al., 2018). However,
using a sleep-low, train-low model, we recently demonstrated that
commencing exercise with stepwise reductions in pre-exercise muscle
glycogen concentrations below 300 mmol (kg dw)−1 (within the range
New Findings
∙ What is the central question of this study?
What is the absolute level of pre-exercise
glycogen concentration required to augment
the exercise-induced signalling response regulating
mitochondrial biogenesis?
∙ What is themain finding and its importance?
Commencing high-intensity endurance exercise
with reduced pre-exercise muscle glycogen
concentrations confers no additional benefit
to the early signalling responses that regulate
mitochondrial biogenesis.
of 300–100 mmol (kg dw)−1) does not augment skeletal muscle cell
signalling in response to exhaustive exercise (Hearris et al., 2019).
Such findings may be related to the fact that commencing exercise
with <300 mmol (kg dw)−1 is already a critical level of absolute
glycogen (as suggested by Impey et al., 2018) that is required to induce
ametabolicmilieu conducive to cell signalling.We therefore suggested
that future research should investigate stepwise reductions in pre-
exercise muscle glycogen within a wider range of pre-exercise muscle
glycogen concentration (i.e. 600–200 mmol (kg dw)−1) in order to
investigate the existence of a potential glycogen threshold and allow
for a better definition of its potential upper and lower limits.
With this in mind, the aim of the present study was to test the
hypothesis that graded pre-exercise muscle glycogen concentrations
modulate the exercise-induced nuclear abundance of AMPK and
PGC-1α protein content as well as the transcription of genes with
putative roles in the regulation of mitochondrial biogenesis. To achieve
our model of graded pre-exercise muscle glycogen concentrations,
we utilised an experimental protocol previously studied in our
laboratory (Impey et al., 2016) consisting of an amalgamation of train-
low protocols whereby participants perform a glycogen depletion
protocol on the evening of Day 1, consume a modified CHO
intake throughout Day 2 and then perform fasted exercise on the
morning of Day 3. In this way, we studied trained male cyclists who
commenced an acute bout of work-matched non-exhaustive high-
intensity interval cycling (HIT) with low (∼200 mmol (kg dw)−1),
moderate (∼350 mmol (kg dw)−1) or high (∼550 mmol (kg dw)−1) pre-
exercise muscle glycogen concentrations.
2 METHODS
2.1 Ethical approval
All subjects provided written informed consent and all procedures
conformed to the standards set by the Declaration of Helsinki (2008).
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F IGURE 1 Schematic overview of the experimental protocol. Following the completion of an evening bout of glycogen-depleting cycling
exercise subjects received three graded levels of CHO in order tomanipulate pre-exercise muscle glycogen on the day of themain experimental
trial. Following an overnight fast, subjects completed a high-intensity intermittent cycling exercise (8× 5min at 80% peak power output). Muscle
biopsies were obtained pre-, post- and 3 h post-exercise
The study was approved by the local Research Ethics Committee of
Liverpool JohnMoores University (ref. no. HM17/SPS/029)
2.2 Participants
Eight endurance-trained amateur male cyclists (mean ± SD: age,
30 ± 10 years; body mass 72.6 ± 9.4 kg; height, 177.0 ± 8.9 cm) took
part in this study. Mean peak oxygen consumption (V̇O2peak) and peak
power output (PPO) for the cohort were 60.4 ± 7.7 ml kg−1 min−1 and
338± 45W, respectively. Cyclists were classed as trained according to
guidelines for subject classification in research (De Pauw et al., 2013;
Jeukendrup, Craig, &Hawley, 2000).A priori sample size determination
was performed, assuming an effect of muscle glycogen on PGC-1α
mRNA of 1.34 (Bartlett et al., 2013), an α-value of 0.05 and a power of
0.80. None of the subjects had any history ofmusculoskeletal or neuro-
logical disease, nor were they under any pharmacological treatment
during the course of the testing period.
2.3 Experimental design
In a repeated measures design, with each experimental trial separated
by a minimum of 7 days, subjects undertook an evening bout of
glycogen depletion exercise followed by the consumption of graded
quantities of CHO (L-CHO: 2 g kg−1, M-CHO: 6 g kg−1, H-CHO:
14g kg−1 for low,mediumandhigh groups, respectively) across a∼36h
period so as tomanipulate pre-exercisemuscle glycogen prior to a bout
of high-intensity interval exercise (8 × 5 min at 80% PPO). All trials
were performed in a randomised and counterbalanced order. Skeletal
muscle biopsies were obtained from the vastus lateralis immediately
before, post- and 3 h post-exercise. An overview of the experimental
protocol is shown in Figure 1.
2.4 Assessment of peak oxygen uptake
At least 7 days prior to experimental trials, all subjects were assessed
for V̇O2peak and PPO on an electronically braked cycle ergometer
(Lode Excalibur Sport, Groningen, Netherlands). Following the
completion of a 10 min warm-up at 75 W, the test began at 100 W
and consisted of 2 min stages with 30W increments in resistance until
volitional exhaustion. During the test, gas exchange measurements
were made using an online gas analysis system (CPX Ultima, MGC
Diagnostics, St Paul, MN, USA). The highest 30 s average of O2
uptake was considered to represent V̇O2peak, which was stated as
being achieved by the following end-point criteria: (1) heart rate
within 10 beats min−1 of age-predicted maximum, (2) respiratory
exchange ratio >1.1, and (3) plateau of oxygen consumption
despite increased workload (Howley, Bassett, & Welch, 1995).
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PPO was taken as the final stage completed during the incremental
test.
2.5 Overview of sleep-low, train-low model
2.5.1 Phase 1: glycogen depletion exercise
In the24hprecedingglycogen-depletingexercise, subjects recordedall
food and drink consumed and were asked to replicate this for all sub-
sequent trials, and also refrained from alcohol and vigorous physical
exercise for the previous 48 h. On the day of glycogen-depleting
exercise (Day 1), subjects reported to the laboratory at approximately
17.00 h to perform a bout of intermittent glycogen-depleting cycling,
as previously completed in our laboratory (Hearris et al., 2019; Impey
et al., 2016; Taylor et al., 2013). The pattern of exercise and total time
to exhaustion in the subject’s initial trial was recorded and replicated
in all subsequent trials. Subjects were permitted to consume water ad
libitum during exercise, with the pattern of ingestion replicated during
subsequent trials.
2.5.2 Phase 2: carbohydrate re-feeding strategy
To facilitate the goal of achieving gradeddifferences inmuscle glycogen
concentrations between trials, subjects were provided with varying
amounts of CHO during the ∼36 h recovery period prior to the sub-
sequent bout of high-intensity interval exercise. Within the immediate
∼4 h recovery period following glycogen-depleting exercise, subjects
in the H-CHO trial were provided with CHO at a rate of 1 g kg−1 h−1
for 3 h from a mixture of CHO drinks and gels (Science in Sport,
Nelson, UK) followed by a high carbohydrate meal providing a further
1 g kg−1 CHO. Subjects in the M-CHO trial consumed 1 g kg−1
CHO immediately following exercise whilst subjects in the L-CHO
trial refrained from CHO intake throughout the remainder of the
evening. Across all trials, subjects also consumed 30 g of whey protein
isolate (Science in Sport) mixed with 500 ml of water immediately
following the cessation of glycogen-depleting exercise to reflect real-
world practice as per current nutritional guidelines (Thomas et al.,
2016).Over the course of the following day (Day 2), subjects consumed
either 10 g kg−1 (H-CHO), or 5 g kg−1 (M-CHO) or 2 g kg−1 (L-CHO)
carbohydrate (i.e. between 09.00 and 21.00 h). In this way, total CHO
intakes in the H-CHO, M-CHO and L-CHO trials equated to 14, 6 and
2 g kg−1 CHO, respectively, over the course of the ∼36 h following
glycogendepletion. In all trials, subjects also consumed2gkg−1 protein
and 1 g kg−1 fat with fluid intake allowed ad libitum. Total energy intake
over the course of the ∼36 h equated to 5306 ± 687, 2978 ± 386 and
1816± 235 kcal in theH-CHO,M-CHOand L-CHO trials, respectively.
2.5.3 Phase 3: high intensity interval cycling
Subjects arrived at the laboratory between 08.00 and 09.00 h on the
morning of Day 3 (in a fasted state), where a venous blood sample
was collected from the antecubital vein and a muscle biopsy taken
from the vastus lateralis. Subjects then completed the high-intensity
interval (HIT) cycling protocol, consisting of 8 × 5 min intervals at
80% PPO, interspersed with 1 min rest. During exercise, heart rate
(HR) was continuously measured and the final HR for each 5 min
interval was recorded whilst ratings of perceived exertion (RPE) were
recorded upon completion of each interval (Borg, 1982). Expired gas
was collected via a mouthpiece connected to an online gas analysis
system (CPX Ultima, MGC Diagnostics, St Paul, MN, USA) for the final
2.5 min of every alternative interval (i.e. intervals 2, 4, 6 and 8) and
substrate utilisation was assessed using the equations of Jeukendrup
& Wallis (2005) given the validity of indirect calorimetry for the
assessment of substrate utilisation at exercise intensities up to 80–
85% V̇O2max (Romijn, Coyle, Hibbert, & Wolfe, 1992). Following the
completion of the exercise bout and collection of the post-exercise
biopsy, subjects were fed 30 g whey protein (Science in Sport) mixed
with 500 ml of water as previously described (Hearris et al., 2019),
which we have previously demonstrated does not influence post-
exercise signalling responses (Taylor et al., 2013)
2.6 Blood analysis
Venous blood samples were collected in vacutainers containing
K2EDTA, lithium heparin or serum separation tubes and stored
on ice or at room temperature until centrifugation at 1500 g for
15 min at 4◦C. Samples were collected immediately prior to and
after exercise. Plasma was aliquoted and stored at −80◦C until
analysis. Samples were later analysed for plasma glucose, lactate,
non-esterified fatty acids (NEFA) and glycerol using commercially
available enzymatic spectrophotometric assays (RX Daytona
Analyser, Randox Laboratories, Crumlin, UK) as per manufacturer
instructions.
2.7 Muscle biopsies
Skeletal muscle biopsies (∼60 mg) were obtained from the vastus
lateralis immediately prior to exercise, immediately upon completion
of the exercise bout and at 3 h post-exercise. Muscle biopsies were
obtained from separate incision sites 2–3 cm apart using a BardMono-
pty Disposable Core Biopsy Instrument (12-gauge × 10 cm length,
Bard Biopsy Systems, Tempe, AZ, USA) under local anaesthesia (0.5%
Marcaine) and immediately frozen in liquid nitrogen and stored at
−80◦C for later analysis.
2.8 Muscle glycogen concentration
Muscle glycogen concentrations were determined according to the
acid hydrolysis method described by Van Loon et al. (van Loon, Saris,
Kruijshoop, & Wagenmakers, 2000). Approximately 2–5 mg of freeze-
dried tissuewaspowdered, dissectedof all visible bloodandconnective
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TABLE 1 Primers used for RT-qPCR
Gene name
Gene






PPARGC1A TGCTAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 67
Tumour protein p53 P53 ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 141
Peroxisome proliferator-
activated receptor δ
PPARδ ATGGAGCAGCCACAGGAGGAAGCC GCATGAGGCCCCGTCACAGC 201
Synthesis of cytochrome c
oxidase
SCO2 CTTCACTCACTGCCCTGACA CGGTCAGACCCAACAGCTT 191
Sirtuin 1 SIRT1 GAGCCATGAAGTATGACAAAGATGA GGCACTTCATGGGGTATGGAA 109
Dynamic-related protein 1 DRP1 CACCCGGAGACCTCTCATTC CCCCATTCTTCTGCTTCCAC 99
Mitofusin 2 MFN2 CCCCCTTGTCTTTATGCTGATGTT TTTTGGGAGAGGTGTTGCTTATTTC 168
Carnitine palmitolytransferase 1
(CPT-1)
CPT-1 GACAATACCTCGGAGCCTCA AATAGGCCTGACGACACCTG 94
Cluster of differentiation 36 CD36 AGGACTTTCCTGCAGAATACCA ACAAGCTCTGGTTCTTATTCACA 199
β2 microglobulin B2M TGCTGTCTCCATGTTTGATGTATCT TCTCGCTCCCCACCTCTAAGT 85
tissue and subsequently hydrolysed by incubation in 500 μl of 1 M
HCl for 3 h at 95◦C. After cooling to room temperature, samples were
neutralised by the addition of 250 μl 0.12 mol l−1 Tris–2.1 mol l−1
KOH saturated with KCl. Following centrifugation, 200 μl of super-
natant was analysed in duplicate for glucose concentration according
to the hexokinase method using a commercially available kit (GLUC-
HK; Randox Laboratories). Glycogen concentrations are expressed as
mmol (kg dw)−1 and intra-assay coefficients of variation were<5%.
2.9 RNA isolation and analysis
Muscle samples (∼20 mg) were homogenised in 1 ml TRIzol reagent
(Thermo Fisher Scientific, Waltham, MA, USA) and total RNA isolated
by phenol–chloroform extraction. Concentrations and purity of RNA
were assessed by UV spectroscopy at optical densities of 260 and
280 nm, using a NanoDrop 3000 (Thermo Fisher Scientific, Rosklide,
Denmark) with an average 260/280 ratio of 1.93 ± 0.08. A quantity of
50 ng total RNAwas used for each 20 μl PCR reaction.
2.10 Reverse transcription–quantitative real-time
polymerase chain reaction
Reverse transcription–quantitative real-time polymerase chain
reaction (RT-qPCR) amplificationswere performed usingQuantiFast™
SYBR® Green RT-PCR one-step kit on a Rotorgene 300Q (Qiagen,
Crawley, UK) supported by Rotorgene Qiagen software (Hercules,
CA, USA). RT-qPCR was performed as follows: 50◦C for 10 min
(reverse transcription/cDNA synthesis), 95◦C for 5 min (transcriptase
inactivation and initial denaturation step), and PCR steps of 40
cycles: 95◦C for 10 s (denaturation), 60◦C for 30 s (annealing and
extension). Upon completion, dissociation/melting curve analyses
were performed to reveal and exclude non-specific amplification or
primer–dimer issues (all melt analysis in this study presented single
reproducible peaks for each target gene suggesting amplification of
a single product). Following initial screening of suitable reference
genes, β2 microglobulin (B2M) showed themost stableCt values across
all RT-PCR runs and subjects, regardless of experimental condition
(25.3± 1.0) andwas therefore selected as the reference gene in all RT-
PCR assays. The average PCR efficiency for all RT-PCR runs (90 ± 2%)
was similar for all genes across all time points and experimental
conditions. As such, the relative gene expression levelswere calculated
using the comparative Ct (2
−ΔΔCt ) equation (Schmittgen & Livak, 2008)
where the relative expression was calculated as 2−ΔΔCt , where Ct
represents the threshold cycle. mRNA expression for all target genes
was calculated relative to the reference gene (B2M) within the same
subject and condition and relative to the pre-exercise value in the
H-CHO condition. The primers used are shown in Table 1.
2.11 Subcellular fractionation
Isolation of nuclear and cytosolic fractions was performed using
the method described by Dimauro, Pearson, Caporossi, & Jackson
(2012). Protein concentrations were determined for both fractions
via a BCA assay (Thermo Fisher Scientific, UK) and validation of
the enrichment of nuclear and cytosolic fractions was confirmed by
blotting the separate fractions against the nuclear protein histone
H3 (Cell Signaling Technology (CST), Danvers, MA, USA: no. 9715,
1:500) and the cytosolic protein lactate dehydrogenase (CST: no.
2012, 1:1000) to demonstrate the absence of major contamination.
Sufficient muscle was available for western blot analysis for seven
subjects.
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F IGURE 2 Skeletal muscle glycogen concentration (a) and utilisation during exercise (b,c). *P< 0.05, significantly different from pre-exercise;
†P< 0.05, significantly different fromH-CHO; ‡P< 0.05, significantly different fromM-CHO
2.12 SDS page and western blotting
Following the determination of protein concentration within each
fraction, samples were resuspended in 4× Laemlli buffer, denatured by
boiling for 5 min at 95◦C and separated by SDS-PAGE using 12%Mini-
Protean TGX Stain-Free Gels (Bio-Rad, Watford, UK). After electro-
phoresis, stain-free gels were activated according to manufacturer
instructions and semi-dry transferred to nitrocellulose membranes
(TransBlot Turbo, Bio-Rad). Following transfer, a stain-free image was
obtained for total protein loading normalisation. Membranes were
subsequently blocked in Tris-buffered saline–Tween containing 5%
non-fat milk for 1 h and incubated overnight in primary antibodies
for AMPKα (CST: no. 2603, 1:1000) and PGC-1α (Sigma-Aldrich,
St-Louis, MO, USA: st-1202, 1:1000) before incubation in relevant
secondary antibody (anti-rabbit: CST: no. 7074, 1:2000) for 1 h at room
temperature the following morning. After washing, membranes were
incubated in a chemiluminescence substrate (Thermo Fisher Scientific,
UK) and visualised using a Chemi-doc MP system (Bio-Rad, Watford,
UK) with band densities quantified using Image Lab software (Bio-Rad,
Watford, UK). The volume density of each target band was normalised
to the total amount of protein loaded into each lane using Stain-Free
technology.
2.13 Statistical analysis
All statistical analyses were performed using SPSS Statistics Version
24 (IBM Corp., Armonk, NY, USA). Comparisons of average physio-
logical responses (e.g. total substrate oxidation) were analysed using a
one-way repeated-measures general linear model whereas changes in
physiological and molecular responses between conditions (i.e. muscle
glycogen, mRNA expression and activity of signalling molecules)
were analysed using a two-way repeated measures general linear
model, where the within factors were time and condition. Where
a significant main effect was observed, pairwise comparisons were
analysed according to the Bonferroni post hoc test in order to locate
specific differences. Pearson’s correlation was used to assess any
associations between variables. All data in text, figures and tables are
presented as means ± SD with P-values ≤ 0.05 indicating statistical
significance.
3 RESULTS
3.1 Skeletal muscle glycogen
Muscle glycogen displayed main effects for condition (P < 0.001), time
(P < 0.001) and a treatment × time interaction effect (P = 0.001).
As such, the exercise and nutritional strategy employed was
successful in achieving graded levels of pre-exercise muscle glycogen
(mmol (kg dw)−1: H-CHO, 531 ± 83; M-CHO, 332 ± 88; L-CHO,
208 ± 79) such that HIT exercise was commenced with three distinct
levels of muscle glycogen (L-CHO vs. M-CHO, P = 0.024; L-CHO
vs. H-CHO, P = 0.001; M-CHO vs. H-CHO, P = 0.022) (Figure 2a).
HIT exercise significantly reduced muscle glycogen concentrations
(main effect of time, P < 0.001), with post-exercise muscle glycogen
concentrations (mmol (kg dw)−1: H-CHO, 270± 88;M-CHO, 173± 74;
L-CHO, 100±42) remaining higher in theH-CHO trial when compared
with the L-CHO trial only (P = 0.013). Furthermore, muscle glycogen
utilisation during HIT exercise displayed a significant main effect
(P=0.001),with glycogenutilisation being significantly higher in theH-
CHO trial (260± 90mmol (kg dw)−1) when compared with the L-CHO
trial (107 ± 55 mmol (kg dw)−1) only (P = 0.011) with no significant
differences observed between M-CHO (159 ± 65 mmol (kg dw)−1)
and either H-CHO or L-CHO trials (P > 0.05) (Figure 2b). However,
the relative utilisation of muscle glycogen during HIT exercise was
similar between all trials (H-CHO, 49.0±14.4%;M-CHO, 47.9±14.95;
L-CHO, 50.1± 13.8%; P= 0.928) (Figure 2c).
3.2 Physiological and metabolic responses to
exercise
Average exercise intensity across the HIT session equated to 85 ± 8%,
85 ± 8% and 89 ± 9% V̇O2peak for H-CHO, M-CHO and L-CHO trials,
respectively. Subjects’ average heart rate (Figure 3a) (beats min−1: H-
CHO, 173 ± 9; M-CHO, 174 ± 8; L-CHO, 176 ± 7) and RPE (Figure 3b)
(arbitrary units: H-CHO, 15±1;M-CHO, 16±2; L-CHO, 16±2) across
the HIT session was similar between trials (P > 0.05). Plasma glucose
displayed a significant main effect for condition (P = 0.001) but no
time or condition × time main effect (P > 0.05). Plasma lactate was
significantly increased by HIT exercise (main effect of time, P = 0.001)
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F IGURE 3 (a–f) Heart rate (a), RPE and plasma (b), glucose (c), lactate (d), NEFA (e), and glycerol (f) pre- and post-exercise. (g,h) Average CHO
(g) and lipid (h) oxidation during exercise. *P< 0.05, significantly different from pre-exercise; †P< 0.05, significantly different fromH-CHO;
‡P< 0.05, significantly different fromM-CHO
but did not display any main effect for condition or condition ×
time (P > 0.05). Plasma NEFA displayed main effects for condition
(P < 0.001), time (P < 0.001) and a condition × time interaction effect
(P=0.001)with plasmaNEFAconcentrations being significantly higher
in the L-CHO trial post-exercise when compared with the H-CHO trial
only (P < 0.001). Plasma glycerol displayed main effects for condition
(P < 0.001), time (P < 0.001) and a condition × time interaction effect
(P = 0.001). Following exercise, plasma glycerol concentrations were
significantly higher in the L-CHO trial when compared with both
M-CHO (P= 0.02) and H-CHO (P < 0.001) trials. Post-exercise plasma
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F IGURE 4 (a,b) Representative western blots for AMPK and PGC-1α (a) and histone H3 and LDH (b), used as indicators of nuclear and
cytosolic enrichment, in both nuclear and cytosolic fractions pre- and post-exercise. (c–e) Protein content of nuclear (c) and cytosolic (d) AMPK and
the ratio between nuclear and cytosolic AMPK (e) post-exercise. (f–h) Protein content of nuclear (f) and cytosolic PGC-1α (g) and the ratio between
nuclear and cytosolic PGC-1α (h) post-exercise. *P< 0.05, significantly different from pre-exercise
glycerol concentrations were also significantly higher in the M-CHO
trial when compared with the H-CHO trial (P = 0.029). Similarly,
subjects in the L-CHO trial achieved significantly lower rates of CHO
oxidation and greater rates of lipid oxidation when compared with
both M-CHO and H-CHO trials (P < 0.005) although no significant
differences were observed between M-CHO and H-CHO trials for
either CHO (P= 0.427) or lipid oxidation (P= 0.687) (Figures 3g and h,
respectively).
3.3 Regulation of mitochondrial biogenesis
related cell signalling
The fractionation protocol was successful in achieving enriched
fractions of both nuclear and cytosolic proteins (Figure 4b). HIT
exercise induced an increase in the content of AMPK protein (main
effect of time; P = 0.025) within the nucleus with no significant
change within the cytosol (no main effect of time; P = 0.20). Despite
this, there was no significant effect of pre-exercise muscle glycogen
concentrations on AMPK localisation (no main effect of condition;
P = 0.207). In contrast, HIT exercise did not induce any change in the
content of PGC-1αprotein in either nuclear or cytosolic (nomain effect
of time or condition, P > 0.05) fractions (Figure 4c–h). With regard to
exercise induced gene expression, HIT exercise induced a significant
increase in PGC-1α, p53 and carnitine palmitoyltransferase 1 (CPT-1)
mRNA expression at 3 h post-exercise (main effect of time, P < 0.05)
but did not display any significantmain effect for condition or condition
× time (P > 0.05) (Figure 5a,b,i). However, PPAR, SCO2, SIRT1, DRP1,
MFN2 and CD36 mRNA expression (Figure 5c–h) was unaffected by
either glycogen availability or theHIT exercise protocol (nomain effect
of time or condition, P> 0.05).
3.4 Correlation between muscle glycogen and cell
signalling responses
The absolute concentration of muscle glycogen immediately post-
exercise demonstrated a significant correlation with PGC-1α mRNA
expression 3 h post-exercise (P = 0.048, r = −0.416; Figure 6). In
contrast, no correlation was observed between post-exercise muscle
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F IGURE 5 PGC-1α (a), p53 (b), PPAR (c), SCO2 (d), SIRT1 (e), DRP1 (f), MFN2 (g), CD36 (h) and CPT-1 (i) mRNA expression pre- and 3 h
post-exercise. *P< 0.05, significantly different from pre-exercise
glycogen concentration and mRNA expression of other target genes
or the nuclear abundance of either AMPK or PGC-1α proteins
(P> 0.05).
4 DISCUSSION
The aim of the present study was to test the hypothesis that graded
pre-exercise muscle glycogen concentrations modulate the exercise-
induced nuclear abundance of AMPK and PGC-1α protein content
as well as the transcription of genes with putative roles in the
regulation of mitochondrial biogenesis. Using trained male cyclists, we
demonstrate that commencing an acute bout of work-matched and
non-exhaustive HIT cycling with graded pre-exercise muscle glycogen
(within a range of 600–200 mmol (kg dw)−1) does not modulate
such early signalling responses. In the context of manipulating CHO
availability around training, our data suggest that the metabolic stress
of HIT exercise may override any potential effect of pre-exercise
muscle glycogen and induce negligible modulatory effects on skeletal
muscle that is already subjected to the local metabolic challenge of
high-intensity exercise.
To address our aim, we utilised an experimental protocol consisting
of a purposeful amalgamation of previous train-low protocols whereby
participants perform a glycogen depletion protocol on the evening of
Day 1, consume a modified CHO intake throughout Day 2 and then
perform fasted exercise on the morning of Day 3. This approach has
been studied previously in our laboratory (Impey et al., 2016) and
provides an extended recovery period following glycogen-depleting
exercise (∼36h) duringwhich larger amounts ofCHOcanbe consumed
when compared to the 12 h period associated with the traditional
sleep-low, train-low protocol (Hearris et al., 2019; Lane et al., 2015).
Indeed, this extended feeding period circumvents the inability to fully
restore muscle glycogen to normative resting concentrations after
∼12 h (Hearris et al., 2019), thus allowing for the investigation of
a wider range of pre-exercise muscle glycogen concentrations (i.e.
600–200 mmol (kg dw)−1). This strategy was effective in achieving
graded differences in pre-exercise muscle glycogen concentrations
(mmol (kg dw)−1: H-CHO, 531 ± 83; M-CHO, 332 ± 88; L-CHO,
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F IGURE 6 Correlation of PGC-1αmRNA (3 h post-exercise) and
post-exercise muscle glycogen concentrations
208 ± 79) and is consistent with what is considered high, normal and
low resting muscle glycogen concentrations in trained males (Areta &
Hopkins, 2018).Whilst we acknowledge that themanipulation of CHO
intake also results in considerable differences in total energy intake,
such short-termdifferences in energy intakedonot appear to influence
themolecular response to exercise (Hammond et al., 2019). In contrast
to our previous work (Hearris et al., 2019), we also employed a work-
matched, non-exhaustive HIT exercise protocol in an attempt to pre-
vent the depletion of muscle glycogen to the absolute concentrations
normally associated with exhaustion (i.e. <100 mmol (kg dw)−1;
Hearris et al., 2019; Impey et al., 2016; Taylor et al., 2013). Despite
differences in absolute glycogen utilisation between trials, we also
observed a comparable relative utilisation (∼50%) between trials, a
magnitude of use that is consistentwith that previously observed using
this exercise protocol (Stepto, Martin, Fallon, & Hawley, 2001). As
such, participants in all trials finished the HIT protocol with absolute
glycogen concentrations<300mmol (kg dw)−1.
In relation to post-exercise signalling, the exercise-induced increase
in nuclear AMPK protein content was not augmented in response to
stepwise reductions in pre-exercise muscle glycogen concentrations,
which is in contrast to previous reports of enhanced nuclear AMPK
content when exercise is commenced with low pre-exercise muscle
glycogen (Steinberg et al., 2006). Given that nuclear AMPK trans-
location in response to exercise may be partly regulated by absolute
glycogen concentrations (due to the physical tethering of AMPK
to the glycogen granule; Steinberg et al., 2006) the magnitude of
muscle glycogen utilisation during exercise may also be important
for AMPK’s disassociation from the granule and subsequent trans-
location to other subcellular regions. With this in mind, the similar
rates of glycogen utilisation (∼50%) between trials, leading to absolute
post-exercise glycogen concentrations <300 mmol (kg dw)−1, may
explain the comparable increases in nuclear AMPK content across
all trials and subsequent discrepancies with previous work. Whilst
the absolute concentrations of muscle glycogen required to facilitate
the subcellular shuttling of AMPK are relatively unknown, post-
exercise glycogen concentrations in the present study are markedly
higher (mmol (kg dw)−1: H-CHO, 270 ± 88; M-CHO, 173 ± 74; L-
CHO, 100 ± 42) when compared with that of the low glycogen
trial in previous work (17 ± 6 mmol (kg dw)−1) (Steinberg et al.,
2006). In fact, post-exercise muscle glycogen concentrations in
the present L-CHO trial are comparable to the control condition
(111±35mmol (kg dw)−1) of previouswork (Steinberg et al., 2006) and
may suggest that the augmentation of nuclear AMPKmayonly occur at
extremely low absolute glycogen concentrations normally associated
with exhaustion.
Irrespective ofmuscle glycogen, the use of high-intensity endurance
exercise within the present study is known to induce significantly
greater metabolic stress and augments the phosphorylation and
activation of AMPK when compared with low-intensity exercise
models (Combes et al., 2015; Egan et al., 2010; Fiorenza et al.,
2018; Wojtaszewski, Nielsen, Hansen, Richter, & Kiens, 2000). Given
that such metabolic fluctuations ultimately regulate signalling kinase
activity, the completion of high-intensity endurance exercise may
provide a sufficient local metabolic challenge to skeletal muscle
whereby reducing pre-exercise muscle glycogen induces negligible
further modulatory effects on skeletal muscle. Although augmented
signalling in response to high-intensity exercise commenced with low
muscle glycogen has been previously observed (Yeo et al., 2010),
recent data suggest this may be explained by the metabolic stress
of training twice per day, as opposed to low pre-exercise glycogen
concentrations per se (Andrade-Souza et al., 2019). Furthermore, as the
exercise-induced activation of AMPK is reduced in trained individuals
(McConell, Wadley, Le plastrier, & Linden, 2020), the use of trained
cyclists within the present study may offer further explanation for the
discrepancy in results when compared with those of Steinberg et al.
(2006).
Despite exercise-induced increases in nuclear AMPK, we failed to
observe concomitant increases in nuclear PGC-1α protein content.
These data are in contrast to most (Andrade-Souza et al., 2019; Little
et al., 2010, 2011) but not all (Tachtsis, Smiles, Lane, Hawley, &Camera,
2016) reports of enhanced nuclear PGC-1α in response to acute
endurance exercise. Our data are, however, in support of previous
findings that demonstrate exercise-induced increases in nuclear PGC-
1α are unaffected by muscle glycogen availability (Andrade-Souza
et al., 2019). The lack of change in nuclear PGC-1α in the present study
may be explained by our chosen sampling time point, given that, in
some cases, increases in nuclear PGC-1α have only been observed 3 h
post-exercise (Little et al., 2011). Indeed, previous data suggest that
the exercise-induced increase in PGC-1α may follow a coordinated,
temporal response later in recovery following its activation via
upstream kinases AMPK and p38 mitogen-activated protein kinase
MAPK within the cytosol immediately post-exercise (Little et al.,
2011). Although not measured in the present study, we have pre-
viously demonstrated increases in AMPK phosphorylation following
a similar bout of high-intensity endurance exercise (Hearris et al.,
2019) irrespective of pre-exercise muscle glycogen concentrations.
However, as PGC-1α is regulated by numerous post-translational
modifications, it is unclear whether an increase in its nuclear protein
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contentwould have been observed later in recoverywithin the present
study.
In relation to exercise-induced gene expression, we demonstrate
that the expression of genes with putative roles in mitochondrial
biogenesis and substrate utilisation is not augmented under conditions
of reduced muscle glycogen concentrations. These candidate genes
were chosen upon the basis of their reported time course of
expression and to allow comparison with previously studied train-
low investigations (Hammond et al., 2019; Impey et al., 2016; Lane
et al., 2015; Psilander et al., 2013). The exercise-induced increase
in PGC-1α, p53 and CPT-1 are consistent with previous reports
following a similar bout of high-intensity running (Hammond et al.,
2019). However, the lack of change in other mitochondria-related
genes is unclear given they display increased expression within the
chosen time course across a range of exercise modalities (Fiorenza
et al., 2018; Impey et al., 2016). In contrast to the previously reported
effects of muscle glycogen concentrations on the regulation of gene
expression (Pilegaard et al., 2002, 2005; Bartlett et al., 2013; Psilander
et al., 2013), these data support our previous findings (Hearris et al.,
2019) and collectively demonstrate that commencing high-intensity
endurance exercise with reduced muscle glycogen concentrations
confers no additional benefit to the expression of genes involved
in mitochondrial biogenesis. The discrepancy in these data may
be explained by the attainment of post-exercise muscle glycogen
concentrations (i.e. <300 mmol (kg dw)−1) associated with augmented
gene expression responses to exercise (Impey et al., 2018) across
all conditions. This raises the possibility that absolute post-exercise
muscle glycogen concentrations (as opposed to pre-exercise) may also
play an important role in regulating mitochondria-related skeletal
muscle signalling responses to exercise given the observed significant
correlation between post-exercise muscle glycogen concentrations
and PGC-1α mRNA. In line with this rationale, our laboratory
has previously demonstrated comparable increases in the mRNA
expression of PGC-1αwith the depletion of muscle glycogen to similar
concentrations (∼100 mmol (kg dw)−1), despite marked differences
in pre-exercise concentrations (600 vs. 300 mmol (kg dw)−1) and
exercise duration (Impey et al., 2016). Furthermore, these findings are
supported by data that demonstrate post-exercise muscle glycogen
concentrations regulate exercise-induced PGC-1α mRNA expression
(Fiorenza et al., 2018; Pilegaard et al., 2005; Psilander, 2014) and
total protein abundance (Mathai, Bonen, Benton, Robinson, &Graham,
2008).
In summary, we provide novel data by demonstrating that
graded pre-exercise muscle glycogen (within a range of 600–
200 mmol (kg dw)−1) does not modulate the exercise-induced
nuclear abundance of AMPK or PGC-1α nor does it affect the
expression of genes with regulatory roles in mitochondrial biogenesis
and substrate utilization. Practically, these data suggest that the
additional stress of low pre-exercise muscle glycogen may not be
required when performing high-intensity exercise that already sub-
jects skeletal muscle to a sufficient metabolic challenge and may
be better suited during conditions that do not elicit such cellular
perturbations (e.g. prolonged low-intensity exercise completed below
lactate threshold). Restriction of CHO availability for the latter
training sessions would also circumvent the impairment in self-
selected training intensity observed when high-intensity exercise is
performed with reduced muscle glycogen (Lane et al., 2013; Yeo et al.,
2008). Given that post-exercise muscle glycogen concentrations were
reduced to low levels across all trials (i.e. 100–250 mmol (kg dw)−1),
our data raise the possibility that the absolute post-exercise muscle
glycogen concentration may also be an important factor in regulating
exercise-induced skeletal muscle signalling responses associated with
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